FABP7 and neoplasm: In conclusion, FABP7 is up-regulated specifically in tumor cells of metastatic NSCLC and endows tumors with metastatic potency via impairing the ubiquitin-proteasomal degradation of β-catenin to activate canonical Wnt signaling.